Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Egesta Lopci

Showing results (1-10 of 196) with videos related to

Pageof 20
Sort By:
Seminars in Nuclear Medicine|February 11, 2025
Current Status of Staging and Restaging Malignant Pleural MesotheliomaEgesta Lopci
Journal of Clinical Medicine|November 13, 2021
Immunotherapy Monitoring with Immune Checkpoint Inhibitors Based on [<sup>18</sup>F]FDG PET/CT in Metastatic Melanomas and Lung CancerEgesta Lopci
Journal of Clinical Medicine|June 10, 2022
Meditating on Cancer Management at the Time of ImmunotherapyEgesta Lopci
European Journal of Nuclear Medicine and Molecular Imaging|May 5, 2017
"The simplest explanation is usually the correct one" - Can Occam's razor be applied for diffuse astrocytoma and paradoxical amino acid metabolism?Egesta Lopci
European Journal of Nuclear Medicine and Molecular Imaging|November 16, 2018
Deauville score: the Phoenix rising from ashesEgesta Lopci, Michel Meignan
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|November 27, 2012
Molecular imaging in oncologyEgesta Lopci, Stefano Fanti
PET Clinics|November 19, 2019
Current Evidence on PET Response Assessment to Immunotherapy in LymphomasEgesta Lopci, Michel Meignan
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2020
Reply: Diagnosis of Hyperprogressive Disease in Patients Treated with Checkpoint Inhibitors Using <sup>18</sup>F-FDG PET/CTAngelo Castello, Egesta Lopci
Cancers|January 11, 2022
Advances in Lung Cancer Imaging and TherapyEgesta Lopci, Silvia Morbelli
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|June 29, 2020
Non-FDG PET/CTEgesta Lopci, Stefano Fanti
Pageof 20

Showing results (1-10 of 196) with videos related to

Sort By:
Pageof 20
Seminars in Nuclear Medicine|February 11, 2025
Current Status of Staging and Restaging Malignant Pleural MesotheliomaEgesta Lopci
Journal of Clinical Medicine|November 13, 2021
Immunotherapy Monitoring with Immune Checkpoint Inhibitors Based on [<sup>18</sup>F]FDG PET/CT in Metastatic Melanomas and Lung CancerEgesta Lopci
Journal of Clinical Medicine|June 10, 2022
Meditating on Cancer Management at the Time of ImmunotherapyEgesta Lopci
European Journal of Nuclear Medicine and Molecular Imaging|May 5, 2017
"The simplest explanation is usually the correct one" - Can Occam's razor be applied for diffuse astrocytoma and paradoxical amino acid metabolism?Egesta Lopci
European Journal of Nuclear Medicine and Molecular Imaging|November 16, 2018
Deauville score: the Phoenix rising from ashesEgesta Lopci, Michel Meignan
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|November 27, 2012
Molecular imaging in oncologyEgesta Lopci, Stefano Fanti
PET Clinics|November 19, 2019
Current Evidence on PET Response Assessment to Immunotherapy in LymphomasEgesta Lopci, Michel Meignan
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2020
Reply: Diagnosis of Hyperprogressive Disease in Patients Treated with Checkpoint Inhibitors Using <sup>18</sup>F-FDG PET/CTAngelo Castello, Egesta Lopci
Cancers|January 11, 2022
Advances in Lung Cancer Imaging and TherapyEgesta Lopci, Silvia Morbelli
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|June 29, 2020
Non-FDG PET/CTEgesta Lopci, Stefano Fanti
Pageof 20